FDA Approved: BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved a supplemental application for the generic combination product butalbital, acetaminophen, and caffeine (Actavis) under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tension-type Headache

Drugs mentioned

• BUTALBITAL, ACETAMINOPHEN AND CAFFEINE (butalbital; acetaminophen; caffeine)

Snippet

SUPPL AP for BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE (BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE)